Search - tctmd.com

Displaying 841 - 860 of 892

Sort: Relevancy | Date

News Conference News TCT 2012

Stroke Prevention Strategies Discussed

October 26, 2012

News Conference News TCT 2012

Two Trials Examine Device-Based PFO Closure

October 25, 2012

News Industry News

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

October 25, 2012

News Industry News

Clinical Trial Shows that PFO Closure With Investigational Device Does Not Decrease Ischemic and Bleeding Events Compared to Medical Therapy

October 25, 2012

Presentation TCT 2012

Atherosclerotic Carotid Bifurcation Stenosis: Primary and Secondary Prevention Strategies

Presenter: William Gray

October 24, 2012

News Conference News TCT 2012

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

October 24, 2012

News Conference News TCT 2012

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

October 23, 2012

News Daily News

El Apixaban Supera a la Warfarina a Todos los Niveles de Riesgo en Pacientes con FA

Caitlin E. Cox

October 04, 2012

News Daily News

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Caitlin E. Cox

October 04, 2012

News Daily News

Efficacy of Clopidogrel Diminished in Diabetics After MI

September 07, 2012

News Conference News ESC 2012

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

Yael L. Maxwell

August 28, 2012

Presentation ESC 2012

Vorapaxar for Secondary Prevention in Patients with Prior Myocardial Infarction

Presenter: 205474|Benjamin Scirica

August 26, 2012

News Conference News ESC 2012

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

August 26, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Daily News

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

L.A. McKeown

August 09, 2012

News Daily News

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

July 31, 2012

News Daily News

Meta-analysis Gives Edge to PFO Closure for Stroke Protection

July 17, 2012

News Daily News

Un Prometedor Antiplaquetario en la Prevención Secundaria de la EAP

Caitlin E. Cox

June 25, 2012

News Daily News

Antiplatelet Shows Promise for Secondary Prevention in PAD

Caitlin E. Cox

June 25, 2012

Presentation

TRA2P TIMI-50 Subanalysis: Vorapaxar for Secondary Prevention in PAD Patients

Presenter: 204599|MP Bonaca

June 22, 2012

Advertisement

Stroke Prevention Strategies Discussed

Two Trials Examine Device-Based PFO Closure

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

Clinical Trial Shows that PFO Closure With Investigational Device Does Not Decrease Ischemic and Bleeding Events Compared to Medical Therapy

Atherosclerotic Carotid Bifurcation Stenosis: Primary and Secondary Prevention Strategies

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

El Apixaban Supera a la Warfarina a Todos los Niveles de Riesgo en Pacientes con FA

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Efficacy of Clopidogrel Diminished in Diabetics After MI

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

Vorapaxar for Secondary Prevention in Patients with Prior Myocardial Infarction

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

Meta-analysis Gives Edge to PFO Closure for Stroke Protection

Un Prometedor Antiplaquetario en la Prevención Secundaria de la EAP

Antiplatelet Shows Promise for Secondary Prevention in PAD

TRA2P TIMI-50 Subanalysis: Vorapaxar for Secondary Prevention in PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content